1 min read
Add as a preferred source on Google

Treace Medical Concepts Q3 Revenue Falls 3.8% to $48.3 Million

The medical device company’s GAAP loss was 19 cents per share, 6 cents better than estimates. Its net loss improved 23% to $12.6 million.

A blank earnings booklet stands beside two metal columns of unequal height / TokenPost.ai
A blank earnings booklet stands beside two metal columns of unequal height / TokenPost.ai

Treace Medical Concepts, Inc. (TMCI) posted third-quarter 2026 revenue of $48.3 million, down 3.8% from a year earlier but $590,000 above estimates.

The company recorded a GAAP loss of 19 cents per share, 6 cents better than estimates. Its net loss improved 23% to $12.6 million.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…